Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

T Cell Sciences receives grant to develop CETP vaccine

Oct. 4, 1996

Alexion authorized to begin second clinical trial with C5 inhibitor

Oct. 4, 1996

TMR as adjunct to bypass surgery

Oct. 4, 1996

Prodesfarma presents cardiovascular candidate

Oct. 4, 1996

Cardiovascular R&D at Takeda

Sep. 27, 1996

New treatment for peripheral vascular diseases cleared for clinical trials in the U.K.

Sep. 27, 1996

Yamanouchi launches treatment for heart failure

Sep. 27, 1996

Japanese and Korean researchers report improved antiarrhythmic agents

Sep. 27, 1996

Hoechst investigates Na+/H+-exchange inhibitors

Sep. 27, 1996

Hoechst claims new antiarrhythmic agents

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...